A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003
High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003
Unruptured Intracranial Aneurysms: Natural History, Clinical Outcome, and Risks of Surgical and Endovascular Treatment
Lancet 362:103-110,90, International Study of Unruptured Intracranial Ane, 2003
Blood Pressure-Lowering for Secondary Prevention of Stroke: ACE Inhibition Is Not the Key
Stroke 34:1334-1335,1335, Bath,P., 2003
Blood Pressure--Lowering for Secondary Prevention of Stroke: ACE Inhibition Is the Key
Stroke 34:1333-1334,1334, Anderson,C., 2003
Lamotrigine for HIV-Associated Painful Sensory Neuropathies
Neurol 60:1508-1514, Simpson,D.M.,et al, 2003
Management of Bacterial Meningitis in Adults
BMJ 326:996-997, Cohen,J., 2003
Hypnic Headache, Clinical Features, Pathophysiology, and Treatment
Neurol 60:905-909, Evers,S.&Goadsby,P.J., 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Pacemaker Therapy for Prevention of Syncope in Patients with Recurrent Severe Vasovagal Syncope
JAMA 289:2224-2229,2272, Connolly,S.J.,et al, 2003
Prophylactic Treatment of Migraine With an Angiotnesin II Receptor Blocker
JAMA 289:65-69, Tronvik,E.,et al, 2003
Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Resolution of Severe Paraplegia Due to Aortic Dissection After CSF Drainage
Neurol 61:142-143, Blacker,D.J., et al, 2003
Laughing Headache: A Novel Type of Triggered Headache with Response to Divalproex Sodium
Headache 43:801-803, Levin,M. &Ward,T.N., 2003
Association Between Migraine and Celiac Disease: Results From a Preliminary Case-Control and Therapeutic Study
, Gabrielli, M.,et al, 2003
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002
Reversible Metronidazole-Induced Lesions of the Cerebellar Dentate Nuclei
NEJM 346:68-69, Woodruff,B.K.,et al, 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Treatment of Women with Epilepsy
Seminars in Neurology 22:289-297, Pack.A.M.&Morrell,M.J., 2002
A New Antiepileptic Drug
JNNP 72:426-429, Shorvon,S.D. &van Rijckevorsel,K., 2002
SUNCT Syndrome: Prolonged Attacks, Refractoriness and Response to Topiramate
Neurol 58:1307, Matharu,M.S.,et al, 2002
Alcohol Consumption and Risk of Ischemic Stroke
Stroke 33:907-912,890, Djousse,L,et al, 2002
Prognostic Significance of Uric Acid Serum Concentration in Patients with Acute Ischemic Stroke
Stroke 33:1048-1052, Chamorro,A.,et al, 2002
Carotid Stenting and Endarterectomy
Stroke 33:1063-1070, Gray,W.A.,et al, 2002
Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002
Use of Ramipril in Preventing Stroke: Double Blind Randomised Trial
BMJ 324:699-702,687, Bosch,J.,et al, 2002
Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002
Prognostic Importance of Leukoaraiosis in Patients with Symptomatic Internal Carotid Artery Stenosis
Stroke 33:1651-1655, Streifler,J.Y.,et al, 2002
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Intranasal Civamide For the Treatment of Episodic Cluster Headaches
Arch Neurol 59:990-994, Saper,J.R.,et al, 2002
A Randomized Trial of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis
Neurol 58:1652-1659, Freitag,F.G.,et al, 2002
Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002
Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002
Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002
West Nile Virus: A Primer for the Clinician
Ann Int Med 137:173-179, Petersen,L.R. &Marfin,A.A., 2002
Serum Potassium Level and Dietary Potassium Intake as Risk Factors for Stroke
Neurol 59:314-320,302, Green,D.M.,et al, 2002
A Double-blind Placebo-controlled Trial of Topiramate Treatment for Essential Tremor
Neurol 59:132-134, Connor,G.S., 2002
Blood Pressure Control in Stroke Patients
Neurol 59:23-25, Messerli,F.H.,et al, 2002
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002
Transoesophageal Echocardiography in Selecting Patients for Anticoagulation After Ischaemic Stroke or Transient Ischaemic Attack
JNNP 73:29-33, Strandberg,M.,et al, 2002
A Meta-Analysis of Coffee Drinking, Cigarette Smoking, and the Risk of Parkinson's Disease
Ann Neurol 52:276-284,261, Hernan,M.A.,et al, 2002
Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002
Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002
Angioplasty and Stenting for Stroke Prevention, Good Questions That Need Answers
Neurol 59:664-668, Chaturvedi,S.&Fessler,R., 2002
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002